Related Experiment Video
Updated: Jun 28, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Rates of HIV immune escape and reversion: implications for vaccination
Miles P Davenport1, Liyen Loh, Janka Petravic
1Centre for Vascular Research, University of NSW, Kensington, NSW 2052, Australia.
Abstract:
HIV-1 mutates extensively in vivo to escape immune control by CD8+ T cells (CTLs). The CTL escape mutant virus might also revert back to wild-type upon transmission to new hosts if significant fitness costs are incurred by the mutation. Immune escape and reversion can be extremely fast if they occur very early after infection, whereas they are much slower when they begin later during infection. Immune escape presents a significant barrier to vaccination, because escape of vaccine-mediated immune responses could neutralise any benefits of vaccination. Here, we consider the dynamics of immune escape and reversion in vivo in natural infection, and suggest how understanding of this can be used to predict optimal vaccine targets and design vaccination strategies that maximise immune control. We predict that inducing synchronous, broad CTL by vaccination should limit the likelihood of viral escape from immune control.
Related Concept Videos
Vaccinations
Retrovirus Life Cycles
Viral Mutations
Vaccines
Size and Structure of Viral Genomes
Cross-reactivity

